CTSW and chronic myelogenous leukemia, BCR-ABL1 positive: A recent study–case report demonstrated the impact of certain proteins, including CTSW, in the absence of relapse in patients with chronic myeloid leukemia (CML) upon discontinuation of tyrosine kinase inhibitor (TKI) therapy.